H. Lundbeck A/S (HLBBF) Q3 2026 Earnings Call Transcript

H. Lundbeck A/S reported its Q3 2026 earnings. Revenue grew by 8% year-over-year, driven by strong sales of its depression and anxiety treatments.

The company maintained its full-year 2026 guidance for revenue and adjusted EBITDA.